Omar Abudayyeh is an faculty member at Harvard Medical School, Investigator at Brigham and Women’s Hospital and Mass General Brigham’s Gene and Cell Therapy Institute, and faculty member with the Department of Stem Cell and Regenerative Biology at Harvard University. He previously was a McGovern Fellow at MIT where he directed his own research group and before that was at Harvard Medical School and MIT as a graduate student in Feng Zhang’s lab at the Broad Institute, where he earned a Ph.D. researching novel CRISPR enzymes for genome editing, therapeutics, and diagnostics. Dr. Abudayyeh has been recognized as Technology Review Innovators Under 35, Bloomberg New Economy Catalyst, Endpoints 20 under 40 Next Generation of Biotech Leaders, 2022 Termeer Scholar, 2018 Forbes 30 under 30, Business Insider 30 under 30, a 2018 TEDMED Hive honoree, and a 2013 Paul and Daisy Soros Fellow. Dr. Abudayyeh graduated from MIT in 2012 and also spent two years studying towards an MD at Harvard Medical School.

Jonathan Gootenberg, Ph.D. is Member of the Faculty at Harvard Medical School, and an Investigator at Beth Israel Deaconess Medical Center and the Center for Vaccine and Virology Research, with affiliations with the Department of Stem Cell and Regenerative Biology at Harvard University and the Department of Genetics at Brigham and Women’s Hospital. Before his position at Harvard Medical School, Dr. Gootenberg led an independent research group at MIT as a McGovern Fellow. He received his Ph.D. in Systems Biology from Harvard University, conducting research with Aviv Regev and Feng Zhang at the McGovern Institute and Broad Institute of MIT and Harvard, and earned his bachelor’s degree in mathematics and biological engineering at MIT. Dr. Gootenberg's work has been recognized with awards such as Forbes 30 Under 30, Technology Review 35 Under 35, Endpoints 20 Under 40, the Termeer Foundation Scholarship, and the American Association for Aging New Investigator award.